U.S. flag

An official website of the United States government

NM_000540.3(RYR1):c.1598G>A (p.Arg533His) AND not provided

Germline classification:
Conflicting interpretations of pathogenicity (6 submissions)
Last evaluated:
Oct 31, 2024
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000119578.50

Allele description [Variation Report for NM_000540.3(RYR1):c.1598G>A (p.Arg533His)]

NM_000540.3(RYR1):c.1598G>A (p.Arg533His)

Gene:
RYR1:ryanodine receptor 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19q13.2
Genomic location:
Preferred name:
NM_000540.3(RYR1):c.1598G>A (p.Arg533His)
Other names:
NM_000540.3(RYR1):c.1598G>A
HGVS:
  • NC_000019.10:g.38455472G>A
  • NG_008866.1:g.26773G>A
  • NM_000540.3:c.1598G>AMANE SELECT
  • NM_001042723.2:c.1598G>A
  • NP_000531.2:p.Arg533His
  • NP_000531.2:p.Arg533His
  • NP_001036188.1:p.Arg533His
  • LRG_766t1:c.1598G>A
  • LRG_766:g.26773G>A
  • LRG_766p1:p.Arg533His
  • NC_000019.9:g.38946112G>A
  • NM_000540.2:c.1598G>A
  • NM_000540.3:c.1598G>A
  • P21817:p.Arg533His
  • p.(Arg533His)
Protein change:
R533H
Links:
UniProtKB: P21817#VAR_008971; dbSNP: rs144336148
NCBI 1000 Genomes Browser:
rs144336148
Molecular consequence:
  • NM_000540.3:c.1598G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001042723.2:c.1598G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
13

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000154485Leiden Muscular Dystrophy (RYR1)
no classification provided
not providedunknownnot provided

PubMed (2)
[See all records that cite these PMIDs]

SCV000203448Eurofins Ntd Llc (ga)
criteria provided, single submitter

(EGL Classification Definitions 2015)
Uncertain significance
(Jun 6, 2016)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link,

SCV001151809CeGaT Center for Human Genetics Tuebingen
criteria provided, single submitter

(CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)
Likely pathogenic
(Aug 1, 2024)
germlineclinical testing

Citation Link,

SCV001782464GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Likely pathogenic
(Oct 31, 2024)
germlineclinical testing

Citation Link,

SCV002502822AiLife Diagnostics, AiLife Diagnostics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Dec 16, 2021)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

SCV003813052Revvity Omics, Revvity
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Aug 30, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown3not providednot providednot providednot providedclinical testing
not providedgermlineyes10not providednot providednot providednot providedclinical testing
not providedunknownnot providednot providednot providednot provided1not providedliterature only

Citations

PubMed

Mutations in RYR1 in malignant hyperthermia and central core disease.

Robinson R, Carpenter D, Shaw MA, Halsall J, Hopkins P.

Hum Mutat. 2006 Oct;27(10):977-89. Review.

PubMed [citation]
PMID:
16917943

Malignant hyperthermia in Japan: mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing.

Ibarra M CA, Wu S, Murayama K, Minami N, Ichihara Y, Kikuchi H, Noguchi S, Hayashi YK, Ochiai R, Nishino I.

Anesthesiology. 2006 Jun;104(6):1146-54.

PubMed [citation]
PMID:
16732084
See all PubMed Citations (8)

Details of each submission

From Leiden Muscular Dystrophy (RYR1), SCV000154485.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providednot provided PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownnot provided1not providednot providednot providednot providednot providednot provided

From Eurofins Ntd Llc (ga), SCV000203448.7

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided3not providednot providedclinical testing PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided3not providednot providednot provided

From CeGaT Center for Human Genetics Tuebingen, SCV001151809.27

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided9not providednot providedclinical testingnot provided

Description

RYR1: PM1, PM5, PS4:Moderate, PS3:Supporting

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided9not providednot providednot provided

From GeneDx, SCV001782464.8

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Published functional studies demonstrate a damaging effect with increased sensitivity to a RYR1 agonist compared to wild-type controls (PMID: 23459219); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 10484775, 24055113, 25637381, 27147545, 30236257, 11668625, 31301762, 33767344, 32381029, 32919876, Kanzaki2022[Paper], 35718563, 34890165, 16732084, 23459219, 30499100, 16084090, 16917943)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From AiLife Diagnostics, AiLife Diagnostics, SCV002502822.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (6)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

From Revvity Omics, Revvity, SCV003813052.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 10, 2024